Gut-Brain Axis: Unveiling the Interplay Between Diabetes Mellitus and Alzheimer's Disease.

The gut-brain axis (GBA) represents a complex bidirectional communication system linking the gastrointestinal tract with the CNS, influencing various physiological processes, including cognition. Emerging research suggests a significant interplay between diabetes mellitus (DM) and Alzheimer's disease (AD) mediated through this axis. DM, characterized by impaired insulin signaling and chronic inflammation, appears to exacerbate the pathology of AD. Key mechanisms include insulin resistance affecting neuronal function and promoting amyloid-beta accumulation and tau phosphorylation, hallmark features of AD. Additionally, dysbiosis of gut microbiota in DM may contribute to neuroinflammation and oxidative stress, further aggravating AD pathology. The gut microbiota can modulate systemic inflammation and metabolic dysfunction, potentially impacting AD progression in DM individuals. Understanding these interactions is crucial for developing targeted therapeutic strategies that address both DM and AD simultaneously. This abstract highlights the intricate relationship between metabolic disorders like DM and neurodegenerative conditions such as AD, emphasizing the role of the GBA as a pivotal area for future research and therapeutic interventions.